000 01230 a2200373 4500
005 20250511133410.0
264 0 _c19790829
008 197908s 0 0 eng d
022 _a0026-0495
024 7 _a10.1016/0026-0495(79)90192-6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSpitz, I M
245 0 0 _aAtropine suppression of basal and metoclopramide-induced human pancreatic polypeptide secretion in man.
_h[electronic resource]
260 _bMetabolism: clinical and experimental
_cMay 1979
300 _a527-30 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAtropine
_xpharmacology
650 0 4 _aDrug Therapy, Combination
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMetoclopramide
_xantagonists & inhibitors
650 0 4 _aMiddle Aged
650 0 4 _aPancreatic Polypeptide
_xmetabolism
650 0 4 _aSex Factors
650 0 4 _aTime Factors
700 1 _aZylber, E
700 1 _aJersky, J
700 1 _aLeroith, D
773 0 _tMetabolism: clinical and experimental
_gvol. 28
_gno. 5
_gp. 527-30
856 4 0 _uhttps://doi.org/10.1016/0026-0495(79)90192-6
_zAvailable from publisher's website
999 _c470125
_d470125